Cystamine protects from 3-nitropropionic acid lesioning via induction of nf-e2 related factor 2 mediated transcription. - Wikidata - thesis-toulmin - TriplyDB

Cystamine protects from 3-nitropropionic acid lesioning via induction of nf-e2 related factor 2 mediated transcription.

Cystamine protects from 3-nitropropionic acid lesioning via induction of nf-e2 related factor 2 mediated transcription.

http://www.wikidata.org/entity/Q33912442

about

Role of Nrf2 in oxidative stress and toxicity The Nrf2-ARE pathway: a valuable therapeutic target for the treatment of neurodegenerative diseases Impaired mitochondrial dynamics and Nrf2 signaling contribute to compromised responses to oxidative stress in striatal cells expressing full-length mutant huntingtin Role of the Vanins-Myeloperoxidase Axis in Colorectal Carcinogenesis.Glucose homeostasis in mice is transglutaminase 2 independent Beneficial effects of Nrf2 overexpression in a mouse model of Alexander disease.Nrf2--a therapeutic target for the treatment of neurodegenerative diseases.Oxidative Stress and Huntington's Disease: The Good, The Bad, and The Ugly.Prospects for cannabinoid therapies in basal ganglia disorders.Monitoring of transglutaminase 2 under different oxidative stress conditions.Role of the Vnn1 pantetheinase in tissue tolerance to stress.A Pharmacogenetic Discovery: Cystamine Protects Against Haloperidol-Induced Toxicity and Ischemic Brain Injury.Are Astrocytes the Predominant Cell Type for Activation of Nrf2 in Aging and Neurodegeneration?Oxidizing effects of exogenous stressors in Huntington's disease knock-in striatal cells--protective effect of cystamine and creatine.Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington's disease.

P2860

Q23919669-7CB17C40-F933-4F54-9235-DC96B4792906 Q26822972-6DAD1B6E-CCF3-4F28-B637-71BF1738FFF1 Q27312215-55F8DFAB-4A8F-4714-BA6A-450BD820AEC9 Q33754814-8AEBEE2C-EF80-4E56-B24D-53432C80ADBF Q34743996-7D7DCE67-D3A3-47F7-B668-90B17A8A4FB7 Q36251679-7F8EDC67-E793-4F64-B556-F71B563A9A4D Q36732766-E4206637-40AE-4175-AB17-151A96AA6F3F Q37643688-5BAECD7E-2788-417E-9450-CB5FC1C907A8 Q37872326-4C73730C-27E7-4ADB-8282-89863234F429 Q37909103-949BCC8B-9CDC-491F-9AFE-21EFCBF95B41 Q38238662-A1395522-67A9-4189-AAE8-036383C5EA02 Q41091940-E11CA7E0-DB22-49B7-A0B0-EF43B2EC3421 Q41662736-FAE4A74B-7F5D-4025-83C8-6DEB0DDE3D89 Q45294879-1BDA845A-7EE1-4873-A24E-EDAA57091137 Q45303268-ADA82F13-089F-408E-9881-011AE67EBCF4

P2860

Cystamine protects from 3-nitropropionic acid lesioning via induction of nf-e2 related factor 2 mediated transcription.

http://www.wikidata.org/entity/Q33912442

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Cystamine protects from 3-nitr ...... ctor 2 mediated transcription.

@ast

Cystamine protects from 3-nitr ...... ctor 2 mediated transcription.

@en

type

label

Cystamine protects from 3-nitr ...... ctor 2 mediated transcription.

@ast

Cystamine protects from 3-nitr ...... ctor 2 mediated transcription.

@en

prefLabel

Cystamine protects from 3-nitr ...... ctor 2 mediated transcription.

@ast

Cystamine protects from 3-nitr ...... ctor 2 mediated transcription.

@en

P1433

Q33912442-B48B7FCE-28AB-4AA8-A3CA-F7598548ABA7

P1476

Q33912442-56D278EF-0D1E-4F58-8BF6-F239B249B605

P2093

Q33912442-0D2B88B7-383B-405C-ADB5-5CE62FFB045B

Q33912442-A6F1CBA4-C4EB-441E-ACFA-D1E20B200544

Q33912442-C69B0D74-BA79-404A-AFDC-B1EDFA2C0F49

Q33912442-F900D87E-34F3-4DA1-AE8C-CDB2828BC755

P2860

Q33912442-045C0199-BD17-4278-BE4B-EE445B51F26D

Q33912442-04E60C48-4406-4D09-A77C-5047B7205C29

Q33912442-050AA581-AB07-4F8C-B0C3-61C102264F18

Q33912442-05CAB8BD-E335-4FB0-A9C0-03A163E6B651

Q33912442-121E9A9C-6483-477C-99BA-36E02F2179F3

Q33912442-155BEFC3-3989-49DB-9A5F-1204FE756887

Q33912442-2242685A-6D8C-409E-9A6E-E9A84FEE183B

Q33912442-268AE76D-862A-44D4-92D1-31D4033FB4B8

Q33912442-26C5912D-D636-4BE5-9412-5F3F4AC7DBD4

Q33912442-2766E3E4-5615-458B-A01A-48CDA1021423

P304

Q33912442-EE67AC42-62C7-48F5-918C-F4062CF950F3

P31

Q33912442-F09F0D4D-F37C-498B-924E-7C66D4ADB733

P356

Q33912442-19A7CC88-DC92-404D-90D4-E8723C0E8CAF

P407

Q33912442-D27CAF65-E06F-4AEB-A854-CEE7DD811DF5

P433

Q33912442-2EAC0418-F3D8-40C4-BE3C-F6467695A7E7

P478

Q33912442-7D112FC1-99D5-4CBD-B438-9557ADD4C2F3

P577

Q33912442-7F1EA2B2-FDE0-4F64-8983-97076A09CD22

P5875

Q33912442-00B72268-95ED-4033-A01F-40AEA4C07DBB

P698

Q33912442-249300F6-9EFB-466E-9E32-3AB5D5419B90

P932

Q33912442-E90C3A1A-FBEC-4614-8C19-9D03CAC866D5

P356

J.EXPNEUROL.2010.04.008

P1433

Experimental Neurology

P1476

Cystamine protects from 3-nitr ...... ctor 2 mediated transcription.

@en

P2093

Delinda A Johnson

http://www.w3.org/2001/XMLSchema#string

Jeffrey A Johnson

http://www.w3.org/2001/XMLSchema#string

Jessica A Townsend

http://www.w3.org/2001/XMLSchema#string

Marcus J Calkins

http://www.w3.org/2001/XMLSchema#string

P2860

Inactivation of human gamma-glutamylcysteine synthetase by cystamine. Demonstration and quantification of enzyme-ligand complexes

Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase.

The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration

Regulation of cellular glutathione

Mitochondrial toxin 3-nitropropionic acid induces cardiac and neurotoxicity differentially in mice

NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development

Nrf2-dependent activation of the antioxidant responsive element by tert-butylhydroquinone is independent of oxidative stress in IMR-32 human neuroblastoma cells.

Protection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription.

Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis.

Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases.

P304

307-317

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EXPNEUROL.2010.04.008

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

224

http://www.w3.org/2001/XMLSchema#string

P577

2010-04-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43226575

http://www.w3.org/2001/XMLSchema#string

P698

20406637

http://www.w3.org/2001/XMLSchema#string

P932

2885467

http://www.w3.org/2001/XMLSchema#string